BioPharma Credit (LSE:BPCR) Ending Cash Position : $120.5 Mil (As of Dec. 2022)

View and export this data going back to 2017. Start your Free Trial

What is BioPharma Credit Ending Cash Position?

BioPharma Credit's Ending Cash Position for the quarter that ended in Dec. 2022 was $120.5 Mil.

BioPharma Credit's quarterly Ending Cash Position declined from Dec. 2021 ($94.7 Mil) to Jun. 2022 ($10.4 Mil) but then increased from Jun. 2022 ($10.4 Mil) to Dec. 2022 ($120.5 Mil).

BioPharma Credit's annual Ending Cash Position increased from Dec. 2021 ($94.7 Mil) to Dec. 2022 ($120.5 Mil) and increased from Dec. 2022 ($120.5 Mil) to Dec. 2023 ($135.1 Mil).

BioPharma Credit Ending Cash Position Historical Data

The historical data trend for BioPharma Credit's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioPharma Credit Ending Cash Position Chart

BioPharma Credit Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

296.64

193.27

94.71

120.53

135.05

BioPharma Credit Semi-Annual Data
	Jun17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Dec23
Ending Cash Position	Get a 7-Day Free Trial							122.48	94.71	10.44	120.53	-

BioPharma Credit Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

BioPharma Credit's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	120.527	+	14.526
	=	135.1

BioPharma Credit's Ending Cash Position for the quarter that ended in Dec. 2022 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10.436	+	110.091
	=	120.5

BioPharma Credit Ending Cash Position Related Terms

Thank you for viewing the detailed overview of BioPharma Credit's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

BioPharma Credit (LSE:BPCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » BioPharma Credit PLC (LSE:BPCR) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

65 Gresham Street, 6th Floor, London, GBR, EC2V 7NQ

Website

https://www.bpcruk.com

BioPharma Credit PLC is an investment company. The investment objective of the company is to generate long-term shareholder returns predominantly in the form of sustainable income distributions from exposure to the life sciences industry. The only reporting segment of the company is the investment in debt assets secured by royalties or other cash flows derived from the sale of approved life sciences products. The company generates revenue in the form of interest income, income from subsidiaries, royalty revenue, make-whole and prepayment income, dividends, and paydown fees. The company earns a majority of its revenue from Investment income.

BioPharma Credit (LSE:BPCR) Headlines

No Headlines